Senti Biosciences Stock Analysis

Senti Stock Analysis Notes

About 21.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.32. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Senti Biosciences recorded a loss per share of 15.59. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 18th of July 2024. Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. The company was incorporated in 2016 and is headquartered in South San Francisco, California. Senti Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 89 people. To find out more about Senti Biosciences contact the company at 650 239 2030 or learn more at https://www.sentibio.com.

Senti Biosciences Investment Alerts

Senti Biosciences Upcoming and Recent Events

Senti Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 45.89 M.

Technical Drivers

As of the 18th of February 2025, Senti Biosciences has the Risk Adjusted Performance of 0.0832, semi deviation of 6.56, and Coefficient Of Variation of 965.91. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Senti Biosciences, as well as the relationship between them.

Senti Biosciences Price Movement Analysis

Senti Biosciences Insider Trading Activities

Senti Biosciences Outstanding Bonds

Senti Biosciences Predictive Daily Indicators

Senti Biosciences Forecast Models

Senti Biosciences' time-series forecasting models are one of many Senti Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Senti Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Senti Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Senti shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Senti Biosciences. By using and applying Senti Stock analysis, traders can create a robust methodology for identifying Senti entry and exit points for their positions.

When running Senti Biosciences' price analysis, check to measure Senti Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senti Biosciences is operating at the current time. Most of Senti Biosciences' value examination focuses on studying past and present price action to predict the probability of Senti Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senti Biosciences' price. Additionally, you may evaluate how the addition of Senti Biosciences to your portfolios can decrease your overall portfolio volatility.